MPN Hub Clinical Trial Club
Logo for the European Board for Accreditation of Continuing Education for Health Professionals

CME accreditation will be provided by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC). You will receive 1 hour of external CME credit for full attendance of the webinar, including completion of the pre-/post-CME test questions and evaluation.

16:30 - 16:35 (CET)
Jean-Jacques Kiladjian

Welcome and introductions

16:35 - 16:50 (CET)
Jean-Jacques Kiladjian

Current clinical landscape in anemic MF

  • Current guidelines
  • Momelotinib approval
  • Treatment challenges and unmet needs
16:50 - 17:05 (CET)
Angela Fleischman

Optimal treatment sequencing in anemic MF

  • When to initiate therapy
  • First-line therapy considerations
  • Relapsed and refractory disease
17:05 - 17:20 (CET)
Angela Fleischman

Ongoing clinical trials and key data

  • NCT03194542 - A phase II study of luspatercept
  • Pacritinib (e.g. NCT02055781)
17:20 - 17:25 (CET)
Jean-Jacques KiladjianAngela Fleischman

Q&A Session

17:25 - 17:30 (CET)
Jean-Jacques KiladjianAngela Fleischman


In compliance with EBAC guidelines, all speakers/chairpersons participating in this program have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organizing Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Registration form

Registration is free. Please complete the form and submit to register.

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy